Folgen
Wolfgang Schechinger
Wolfgang Schechinger
RBF Biotech - Custom Antibodies for You!
Bestätigte E-Mail-Adresse bei rub.de - Startseite
Titel
Zitiert von
Zitiert von
Jahr
The proteomic signature of insulin-resistant human skeletal muscle reveals increased glycolytic and decreased mitochondrial enzymes
J Giebelstein, G Poschmann, K Højlund, W Schechinger, JW Dietrich, ...
Diabetologia 55 (4), 1114-1127, 2012
742012
Generation of novel single-chain antibodies by phage-display technology to direct imaging agents highly selective to pancreatic β-or α-cells in vivo
S Ueberberg, JJ Meier, C Waengler, W Schechinger, JW Dietrich, ...
Diabetes 58 (10), 2324-2334, 2009
602009
Synthesis and evaluation of a glibenclamide glucose-conjugate: a potential new lead compound for substituted glibenclamide derivatives as islet imaging agents
S Schneider, S Ueberberg, A Korobeynikov, W Schechinger, ...
Regulatory peptides 139 (1), 122-127, 2007
512007
Directed evolution of a lysosomal enzyme with enhanced activity at neutral pH by mammalian cell-surface display
KC Chen, CH Wu, CY Chang, WC Lu, Q Tseng, ZM Prijovich, ...
Chemistry & biology 15 (12), 1277-1286, 2008
392008
Prolonged glucose infusion into conscious rats inhibits early steps in insulin signalling and induces translocation of GLUT4 and protein kinase C in skeletal muscle
B Houdali, V Nguyen, HPT Ammon, M Haap, W Schechinger, F Machicao, ...
Diabetologia 45 (3), 356-368, 2002
302002
In vitro phage display in a rat beta cell line: a simple approach for the generation of a single-chain antibody targeting a novel beta cell-specific epitope
S Ueberberg, D Ziegler, W Schechinger, JW Dietrich, S Akinturk, HH Klein, ...
Diabetologia 53 (7), 1384-1394, 2010
182010
Signalization of Akt/PKB in the placenta, skeletal muscle and adipose tissue of preeclampsia patients
RB Orcy, S Schroeder, SH Martins-Costa, JGL Ramos, W Schechinger, ...
Gynecologic and obstetric investigation 66 (4), 231-236, 2008
142008
Human beta-glucuronidase mutants with elevated enzymatic activity under physiological conditions and method for identifying such
S Roffler, CH Wu, W Schechinger, KC Chen, Z Prijovic
US Patent 8,491,891, 2013
62013
No difference in insulin stimulated AKT and AS160 phosphorylation but decreased insulin effect on FoxO4 abundance in skeletal muscle of obese and obese type 2-diabetic subjects
J Giebelstein, L Plettig, W Schechinger, K Hojlund, K Levin, ...
Experimental and Clinical Endocrinology & Diabetes 122 (03), OP2_05, 2014
12014
No difference in insulin stimulated AKT and AS160 phosphorylation but decreased insulin effect on FoxO4 abundance in skeletal muscle of obese and obese type 2-diabetic subjects
J Giebelstein, L Plettig, W Schechinger, K Hojlund, K Levin, ...
Experimental and Clinical Endocrinology & Diabetes 122 (03), OP2_05, 2014
12014
Proteome analysis in muscle biopsies of lean, obese and obese type 2 diabetic patients
HH Klein, J Giebelstein, JW Dietrich, W Schechinger, G Poschmann, ...
DIABETOLOGIA 52, S99-S99, 2009
12009
Generation of Novel Single Chain Antibodies by Phage Display Technology To Direct Biomolecules Highly Selective to Pancreatic beta-Cells In Vivo
S Ueberberg, JJ Meier, W Schechinger, I Schmitz, A Tannapfel, ...
DIABETES 58, A92-A93, 2009
12009
Potential role of prohibitin-1 in type 2-diabetes-associated insulin resistance
W Schechinger, K Højlund, K Levin, H Beck-Nielsen, H Klein
68th Annual Meeting of the American Diabetes Association (ADA), 2008
12008
Engineering, Expression, and Purification of a Single-Chain Fragment for Beta-Cell Targeting
JH Juang, W Schechinger, ST Wu, CR Shen
DIABETES 66, A486-A486, 2017
2017
Engineering of a novel beta cell specific single chain variable fragment (ScFv) for imaging
W Schechinger, CR Shen, ST Wu, JH Juang
DIABETOLOGIA 59, S225-S226, 2016
2016
Engineering of a novel beta cell specific single chain variable fragment (ScFv) for imaging
W Schechinger, CR Shen, ST Wu, JH Juang
DIABETOLOGIA 59, S225-S226, 2016
2016
Insulin stimulates FoxO4 protein abundance in human skeletal muscle in lean healthy but not in obese subjects with or without type 2 diabetes
J Giebelstein, W Schechinger, LM Plettig, K Hojlund, K Levin, ...
Diabetologie und Stoffwechsel 9 (S 01), FV41, 2014
2014
Insulin stimulates FoxO4 protein abundance in human skeletal muscle in lean healthy but not in obese subjects with or without type 2 diabetes
J Giebelstein, W Schechinger, LM Plettig, K Hojlund, K Levin, ...
Diabetologie und Stoffwechsel 9 (S 01), FV41, 2014
2014
Proteomanalyse bei Skelettmuskelbiopsien von schlanken, adipösen und adipösen Probanden mit Diabetes
J Giebelstein, JW Dietrich, W Schechinger, G Poschmann, K Podwojski, ...
Diabetologie und Stoffwechsel 5 (S 01), P279, 2010
2010
Entwicklung eines β-Zell spezifischen Kontrastmittels zur nicht-invasiven Bestimmung der β-Zellmasse
S Ueberberg, W Schechinger, JW Dietrich, JJ Meier, A Tannapfel, ...
Diabetologie und Stoffwechsel 4 (S 01), FV_51, 2009
2009
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20